Recent Episodes...
Featured
Interviews...
Featured
With 4 precision treatments now approved or in late-stage development, we explore how the expanding achondroplasia treatment landscape could shape growth, body proportionality, function, and family decision-making.
Monisha Sebastin explains how the Global Genetics Directory connects genetics professionals worldwide to support patient care and collaboration.
Dr. Jennifer Brown and her daughter Lillian Isabella explore the realities of PKU, from food and family life to mental health and independence.
Interviews...
With 4 precision treatments now approved or in late-stage development, we explore how the expanding achondroplasia treatment landscape could shape growth, body proportionality, function, and family decision-making.
Monisha Sebastin explains how the Global Genetics Directory connects genetics professionals worldwide to support patient care and collaboration.
Dr. Jennifer Brown and her daughter Lillian Isabella explore the realities of PKU, from food and family life to mental health and independence.
Pioneering prenatal genetics researcher Dr. Diana Bianchi shares what the IDENTIFY study is revealing about unexpected cancer signals in cfDNA screening.
Genetic counselor Amy Patterson kicks off our three-part hypophosphatasia (HPP) series explaining the disorder and diagnosis.
Alongside his wife, Liz, Art shares how family health history and genetic testing finally connected the clues, and inspired their mission for earlier detection and advocacy.
Dr. Madhuri Hegde and Mackenzie Mosera Derby kick off a new series on the health economics of genetic testing, starting with insurance coverage and barriers to access.
Actor and former professional wrestler Tyler Mane shares his male breast cancer diagnosis, the importance of self-advocacy, and why men need to know their hereditary cancer risk.
Melanie Hardy and Amy Shikany take listeners inside the American Board of Genetic Counselor’s (ABGC) board exam and explain how to prepare with the latest 2026 resources.
Our third installment of our Achondroplasia Series, sponsored by BioMarin, explores the FDA approved vosoritide treatment with the doctor who led the clinical trials.